Human natural killer cells augment B cell responses to porcine xenoantigens.
Transplantation Immunology, Department of Surgery, Columbia University, New York, New York, USA.
R
R
John
P
P
Kwiatkowski
N
N
Edwards
S F
SF
Wang
S
S
Itescu
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000917:Antibody Formation; D015478:Antigens, Heterophile / Q000276:immunology*; D001011:Aorta; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology*; D019013:CD40 Antigens / Q000276:immunology; D023201:CD40 Ligand; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology* / Q000528:radiation effects; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000276:immunology; D013552:Swine
D000911:Antibodies, Monoclonal; D015478:Antigens, Heterophile; D019013:CD40 Antigens; D008562:Membrane Glycoproteins; D023201:CD40 Ligand